|
Sep 27
|
Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?
|
|
Sep 26
|
ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%
|
|
Jun 25
|
Alimera (ALIM) Rises on Merger Deal With ANI Pharmaceuticals
|
|
Jun 25
|
ANI Pharmaceuticals’ CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner
|
|
Jun 24
|
Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal
|
|
Jun 24
|
Alimera Sciences shares jump by 77% after being acquired by ANI
|
|
Jun 24
|
ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences
|
|
Jun 23
|
ANI Pharmaceuticals (NASDAQ:ANIP) shareholders are still up 77% over 3 years despite pulling back 6.5% in the past week
|
|
Jun 21
|
Strength Seen in Gilead (GILD): Can Its 8.5% Jump Turn into More Strength?
|
|
Jun 13
|
Implied Volatility Surging for ANI Pharmaceuticals (ANIP) Stock Options
|
|
Jun 6
|
Insider Sale: SVP & CFO Stephen Carey Sells 5,000 Shares of ANI Pharmaceuticals Inc (ANIP)
|
|
May 16
|
Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus
|
|
May 16
|
Vanda (VNDA) Rises on Positive Data From Motion Sickness Study
|
|
May 15
|
FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
|
|
May 14
|
Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
|
|
May 14
|
Novo Nordisk (NVO) Up 3% as Haemophilia Drug Meets Study Goals
|
|
May 14
|
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
|
|
May 13
|
ANI Pharmaceuticals, Inc. Just Beat EPS By 459%: Here's What Analysts Think Will Happen Next
|
|
May 13
|
ANI Pharmaceuticals Inc (ANIP) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...
|
|
May 11
|
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Q1 2024 Earnings Call Transcript
|